Yesterday, Dec. 16, 2015, 113 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $10.88 to $18,402,925.00.

Highlighted Stocks Traded by Insiders:

Trustco Bank Corp N Y (TRST) - FREE Research Report

De Gennaro Dennis A, who is Director at Trustco Bank Corp N Y, bought 7,971 shares at $6.27 on Dec. 16, 2015. Following this transaction, the Director owned 92,867 shares meaning that the stake was boosted by 9.39% with the 7,971-share transaction.

The shares most recently traded at $6.39, up $0.12, or 1.88% since the insider transaction. Historical insider transactions for Trustco Bank Corp N Y go as follows:

  • 4-Week # shares bought: 1,654
  • 4-Week # shares sold: 12,500
  • 12-Week # shares bought: 1,654
  • 12-Week # shares sold: 12,500
  • 24-Week # shares bought: 20,664
  • 24-Week # shares sold: 12,500

The average volume for Trustco Bank Corp N Y has been 336,600 shares per day over the past 30 days. Trustco Bank Corp N Y has a market cap of $597.8 million and is part of the financial sector and banking industry. Shares are down 12.53% year-to-date as of the close of trading on Wednesday.

TrustCo Bank Corp NY operates as the holding company for Trustco Bank that provides personal and business banking services to individuals, partnerships, and corporations. The stock currently has a dividend yield of 4.18%. The company has a P/E ratio of 13.9. Currently, there are no analysts who rate Trustco Bank Corp N Y a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TRST - FREE

TheStreet Quant Ratings

rates Trustco Bank Corp N Y as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Trustco Bank Corp N Y Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

LinkedIn (LNKD) - FREE Research Report

Callahan Michael John, who is VP, GC and Secretary at LinkedIn, sold 111 shares at $232.46 on Dec. 16, 2015. Following this transaction, the VP, GC and Secretary owned 31,159 shares meaning that the stake was reduced by 0.35% with the 111-share transaction.

The shares most recently traded at $229.61, down $2.85, or 1.24% since the insider transaction. Historical insider transactions for LinkedIn go as follows:

  • 4-Week # shares sold: 488
  • 12-Week # shares sold: 21,550
  • 24-Week # shares sold: 52,502

The average volume for LinkedIn has been 1.6 million shares per day over the past 30 days. LinkedIn has a market cap of $26.5 billion and is part of the technology sector and internet industry. Shares are up 2.09% year-to-date as of the close of trading on Wednesday.

LinkedIn Corporation, together with its subsidiaries, operates an online professional network worldwide. Currently, there are 23 analysts who rate LinkedIn a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LNKD - FREE

TheStreet Quant Ratings

rates LinkedIn as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full

LinkedIn Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

US Physical Therapy (USPH) - FREE Research Report

Mcafee Lawrance W, who is Chief Financial Officer at US Physical Therapy, sold 4,000 shares at $51.24 on Dec. 16, 2015. Following this transaction, the Chief Financial Officer owned 38,852 shares meaning that the stake was reduced by 9.33% with the 4,000-share transaction.

The shares most recently traded at $50.86, down $0.38, or 0.75% since the insider transaction. Historical insider transactions for US Physical Therapy go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 25,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 33,299
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 49,897

The average volume for US Physical Therapy has been 111,400 shares per day over the past 30 days. US Physical Therapy has a market cap of $632.4 million and is part of the health care sector and health services industry. Shares are up 21.28% year-to-date as of the close of trading on Wednesday.

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics in the United States. The stock currently has a dividend yield of 1.18%. The company has a P/E ratio of 29.4. Currently, there are 2 analysts who rate US Physical Therapy a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on USPH - FREE

TheStreet Quant Ratings

rates US Physical Therapy as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

US Physical Therapy Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.